Posted by jrbecker on May 9, 2003, at 11:10:39
In reply to To Pfinstegg - CRF Antagonists, posted by denise528 on May 8, 2003, at 12:25:26
Have you called all of the other companies involved in CRF-1 pipeline research: Pfizer, Janssen(neurocrine's partner), GSK, Bristol-Meyer's Squibb?
> Hi Pfinstegg,
>
> After ringing around I finally got the PM at Neurocrine to give me some information regarding the CRF Antagonist trials although Neurocrine are no longer doing them she said as follows:-
>
> I found out some info from a colleague at GSK. The CRF1 Antagonist patient
> trials will not occur in the near future. Here is her recommendation for
> searching the GSK website for trials with other GSK drugs:
>
> "...the next patient trials with any CRF1 backup will not be projected to
> inititate until,....best case scenario......at least sometime in 2005. If
> she'd be interested in looking at our web site, which would point her
> possibly to other compound trials she may be interested in, she could check
> out www.gsk.com under R&D. There are several links to different trials
> under this.
>
> Right now we have clinical trials ongoing in depression for Lamictal,
> Wellbutrin SR, Paxil CR, and several new compounds in development, however,
> I'm limited as to how much info I can share on these beyond what is
> currently on the website."
>
> I can't understand it, why are they still doing trials for lamictal, wellbutrin, Paxil which have been around for years and yet they're leaving the CRF antagonists until 2005.
>
>
> Denise
poster:jrbecker
thread:225118
URL: http://www.dr-bob.org/babble/20030505/msgs/225383.html